COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color
COVIDVaxStories: A Pilot Double-blind Randomized, Parallel Design Trial of Storytelling to Reduce COVID-19 Vaccine Hesitation in Populations of Color Using a Respondent-driven Sampling Design
1 other identifier
interventional
100
1 country
1
Brief Summary
Pilot randomized controlled trial testing the investigator's previously developed storytelling method to create an interactive, multi-media storytelling intervention to address community-identified reasons for vaccine hesitancy among Black and Hispanic individuals in Central Massachusetts
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2023
CompletedStudy Start
First participant enrolled
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
March 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 9, 2024
CompletedDecember 4, 2024
December 1, 2024
1.2 years
May 1, 2023
December 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Vaccine Hesitancy
Validated vaccine hesitancy questionnaire
From beginning of survey to end of survey typically, 30 minutes
Secondary Outcomes (1)
Vaccine Uptake
6 months after participation
Study Arms (2)
Storytelling
EXPERIMENTALParticipants will view short video narratives of community members speaking about why they chose to get vaccinated against Coronavirus Disease of 2019 (COVID-19) and how they overcame hesitancy. Participants will also view the informational videos described below.
Learn More
OTHERParticipants will view short informational videos that provide factual information on the COVID-19 vaccines.
Interventions
Narrative stories will be videos that are 2-3 minutes long and will show community members speaking based on community identified themes.
Informational videos that are of similar length and on the same topic as the storytelling videos.
Eligibility Criteria
You may qualify if:
- \>= 18 years of age
- identifies as Black and/or Hispanic
- lives in Massachusetts
- vaccinated for COVID-19.
You may not qualify if:
- Unable to provide consent in English or Spanish
- Has not completed the primary series of COVID-19 vaccinations (2 shots for Moderna or Pfizer, one shot for Johnson \& Johnson).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Massachusetts, Worcesterlead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
University of Massachusetts Chan Medical School
Worcester, Massachusetts, 01605, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will view either storytelling videos or learn more videos. They will not know which video they will get ahead of time nor will they know that they may get one or the other.
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair, Population and Quantitative Health Sciences
Study Record Dates
First Submitted
May 1, 2023
First Posted
March 7, 2024
Study Start
May 19, 2023
Primary Completion
August 9, 2024
Study Completion
August 9, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share